Dabigo 75 mg

Dabigo 75 mg contains the active ingredient Dabigatran, the first new oral anticoagulant to be approved to prevent stroke in people with non-valvular atrial fibrillation (A specific type of irregular heart rhythm). Treatment should be continued life-long. In case of intolerability, patients are instructed to contact their doctors.